Insilico Medicine (“Insilico”), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has demonstrated that it can predict the outcome of Phase II to Phase III clinical trial success using its proprietary transformer-based AI clinical trial prediction tool called inClinico with a high degree of accuracy.
HIPAA & Modern Healthcare Realities: Dispelling Data Sharing Myths
Timi Leslie, President, BluePath Health and Exec Director of the Connecting for Better Health Coalition Myths in healthcare data sharing often cloud the understanding of
July 23, 2024